LobbyingDatavant lobbying by quarter
Datavant's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q1 2023; the issues it reports most are Health Issues and Budget/Appropriations.
Datavant
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $42.5K | 1 |
| Q2 2023 | $37.7K | 1 |
| Q3 2023 | $48.7K | 1 |
| Q4 2023 | $48.7K | 1 |
| Q1 2024 | $78.1K | 1 |
| Q2 2024 | $128.1K | 2 |
| Q3 2024 | $115K | 2 |
| Q4 2024 | $70K | 2 |
| Q1 2025 | $60K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$366.9K · 17 reports
- Budget and appropriations$226.9K · 10 reports
- Medicare and Medicaid$167.5K · 10 reports
- Welfare$140K · 7 reports
- Science and technology$27.5K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES17 reports
- SENATE17 reports
- Health & Human Services, Dept of (HHS)7 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Office of Management & Budget (OMB)2 reports
- White House Office2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Alston & Bird | $420K | 7 quarters |
| In-houseDatavant | $398.7K | 7 quarters |
| Forbes-Tate | $110K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALEXANDER GRAF | Deputy Assistant Secretary for Legislation, Department of Health and Human Services; Senate Finance Health Subcommittee Staff Director, Legislative Assistant, Legislative Aide, Deputy Scheduler, Staff Assistant, Senator Debbie Stabenow. | Q1 2025 |
| SAMANTHA SEGALL | Professional Staff, Ken Calvert | Q3 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Alston & Bird | $60K |
| 04/20for Q1 | Alston & Bird | $60K |
| 03/03for Q1 2025 | Alston & Bird | $60K |
| 01/20for Q4 2025 | Alston & Bird | $60K |
| 25/10/20for Q3 2025 | Alston & Bird | $60K |
| 25/07/21for Q2 2025 | Alston & Bird | $60K |
| 25/04/21for Q1 2025 | Alston & Bird | $60K |
| 25/01/22for Q4 2024 | Forbes-Tate | $10K |
| 25/01/21for Q3 2024 | In-house | $65K |
| 25/01/21for Q4 2024 | Alston & Bird | $60K |
| 24/10/30for Q4 2024 | Alston & Bird | Under $5,000 |
| 24/10/17for Q3 2024 | Forbes-Tate | $50K |
| 24/10/16for Q3 2024 | In-house | $65K |
| 24/07/22for Q2 2024 | In-house | $78.1K |
| 24/07/17for Q2 2024 | Forbes-Tate | $50K |
| 24/07/14for Q2 2024 | Forbes-Tate | $30K |
| 24/04/29for Q2 2024 | Forbes-Tate | Under $5,000 |
| 24/04/22for Q1 2024 | In-house | $78.1K |
| 24/01/19for Q4 2023 | In-house | $48.7K |
| 23/10/19for Q3 2023 | In-house | $48.7K |